You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

individualized dose-escalation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Esophagus Cancer, Appendix Cancer Trial (FOX dose-escalation algorithm)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • FOX dose-escalation algorithm
  • (no location specified)
Mar 24, 2023

Dementia Trial in Hong Kong (Individualized music playlist, Preferred music, Usual care)

Not yet recruiting
  • Dementia
  • Individualized music playlist
  • +2 more
  • Hong Kong, Hong Kong
    School of Nursing, The Hong Kong Polytechnic University
Oct 26, 2023

Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • HP518 - Dose Escalation
  • HP518 -Dose Expansion
  • (no location specified)
Dec 1, 2023

Glioblastoma Trial (Dose escalation of radiation dose beyond the therapeutic standard)

Not yet recruiting
  • Glioblastoma
  • Dose escalation of radiation dose beyond the therapeutic standard
  • (no location specified)
May 13, 2023

Head and Neck Squamous Cell Carcinoma Trial in Delhi (DE-HyART, Standard Arm, Cisplatin injection)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • DE-HyART
  • +3 more
  • Delhi, India
    Rajiv Gandhi Cancer Institute and Research Centre
Oct 20, 2023

Advanced Solid Tumor Trial (STI-7349, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Aug 3, 2023

Breast Cancer Trial (Standard of care administration of Endocrine therapy, Dose-frequency escalation administration of Endocrine

Not yet recruiting
  • Breast Cancer
  • Standard of care administration of Endocrine therapy
  • Dose-frequency escalation administration of Endocrine therapy
  • (no location specified)
Feb 22, 2023

Atopic Dermatitis Trial (Dupilumab - Discontinuation, Dupilumab - Dose Reduction, Dupilumab - Standard Dose)

Not yet recruiting
  • Atopic Dermatitis
  • Dupilumab - Discontinuation
  • +2 more
  • (no location specified)
Nov 2, 2023

Healthy Trial (BG136, Placebo)

Not yet recruiting
  • Healthy
  • (no location specified)
Aug 2, 2023

Corneal Epithelial Degeneration Trial in Cypress (TTHX1114(NM141) Ophthalmic Solution)

Recruiting
  • Corneal Epithelial Degeneration
  • TTHX1114(NM141) Ophthalmic Solution
  • Cypress, California
    Trefoil Clinical Site #132
Mar 3, 2023

Head Neck Cancer Trial in Tübingen (Real-time ADC-guided response adaptive Boost in HNC)

Recruiting
  • Head and Neck Cancer
  • Real-time ADC-guided response adaptive Boost in HNC
  • Tübingen, BW, Germany
    UKT Radiooncology
Jan 31, 2022

Recurrent or Metastatic Solid Tumors Trial (Recombinant Anti-EpCAM-CD3 Antibody Injection)

Not yet recruiting
  • Recurrent or Metastatic Solid Tumors
  • Recombinant Anti-EpCAM-CD3 Antibody Injection
  • (no location specified)
Oct 17, 2023

BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms Trial in Wahroonga, Tauranga (RT-310)

Not yet recruiting
  • BPH (Benign Prostatic Hyperplasia)
  • Lower Urinary Tract Symptoms
  • RT-310
  • Wahroonga, New South Wales, Australia
  • +1 more
Nov 13, 2023

Prostate Adenocarcinoma Trial in Madrid (Prostate SBRT (stereotactic body radiation therapy) with focal boost)

Not yet recruiting
  • Prostate Adenocarcinoma
  • Prostate SBRT (stereotactic body radiation therapy) with focal boost
  • Madrid, Spain
    La Princesa University Hospital, Health Research Institute, Madr
Jun 16, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in Bloemfontein, Cape Town, Pretoria (BCX10013)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Bloemfontein, South Africa
  • +2 more
Oct 20, 2023

Idiopathic Pulmonary Fibrosis Trial in Stanford (Artesunate Oral Product)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Artesunate Oral Product
  • Stanford, California
    Stanford University
Aug 4, 2023

Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial (Defibrotide)

Not yet recruiting
  • Sinusoidal Obstruction Syndrome
  • Veno-occlusive Disease
  • (no location specified)
Aug 4, 2023

Solid Tumor, Adult Trial in Belgium, France (DT-9081 - dose escalation, DT-9081 - expansion)

Recruiting
  • Solid Tumor, Adult
  • DT-9081 - dose escalation
  • DT-9081 - expansion
  • Anderlecht, Belgium
  • +3 more
Jan 5, 2023

Pain, Postoperative Trial in Seongnam-si (GB-6002, Placebo, Naropin injection)

Recruiting
  • Pain, Postoperative
  • Seongnam-si, Korea, Republic of
    Seoul National University Bundang Hospital
Oct 17, 2023

Crohn Disease Trial in Zaventem (Ustekinumab)

Recruiting
  • Crohn Disease
  • Zaventem, Belgium
    Ingrid Arijs
Dec 13, 2022

Ovarian Cancer Trial in Lexington (Lapatinib and Paclitaxel)

Recruiting
  • Ovarian Cancer
  • Lapatinib and Paclitaxel
  • Lexington, Kentucky
    Markey Cancer Center
Dec 2, 2022

LGMD2C Trial (ATA-200)

Not yet recruiting
  • LGMD2C
  • ATA-200
  • (no location specified)
Aug 1, 2023

High Dose Re-Irradiation Utilizing Advanced Deformable Image

Not yet recruiting
  • Solid Tumor
  • Re-irradiation
  • (no location specified)
Jun 13, 2022

Liver Cancer, Hepatocellular Carcinoma Trial (Regorafenib Oral Product)

Not yet recruiting
  • Liver Cancer
  • Hepatocellular Carcinoma
  • Regorafenib Oral Product
  • (no location specified)
Nov 17, 2022

Ovarian Cancer Trial in Lexington (Artemisia annua 450mg, Artemisia annua 900mg, Artemisia annua 1350mg)

Recruiting
  • Ovarian Cancer
  • Artemisia annua 450mg
  • +4 more
  • Lexington, Kentucky
    University of Kentucky
Jan 4, 2023